Indication

Clostridioides difficile infection

Clostridioides difficile infection is a bacterial disease of the gastrointestinal tract caused by the toxin-producing, spore-forming anaerobic bacterium *Clostridioides difficile* (formerly *Clostridium difficile*). Read more about Clostridioides difficile infection

70 drugs 55 manufacturers

Advertisement

Drugs that treat it

Common Clostridioides difficile infection therapies.

Showing 1–9 of 70 drugs

Filter & compare in the drug finder →Opens the drug finder with Clostridioides difficile infection preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Clostridioides difficile infection.

Clostridioides difficile infection is a bacterial disease of the gastrointestinal tract caused by the toxin-producing, spore-forming anaerobic bacterium *Clostridioides difficile* (formerly *Clostridium difficile*).

It most commonly affects adults with recent broad-spectrum antimicrobial exposure, advanced age, or prolonged healthcare facility contact, where disruption of the normal colonic microbiota permits bacterial spore germination and overgrowth.

Pathogenesis is primarily mediated by bacterial exotoxins (toxin A and toxin B) that damage the intestinal mucosal epithelium, induce intense localized inflammation, and alter fluid secretion.

Clinical manifestations range from mild watery diarrhea, abdominal cramping, and leukocytosis to life-threatening complications such as pseudomembranous colitis, toxic megacolon, bowel perforation, sepsis, and shock.

Personalize your experience

Follow Clostridioides difficile infection and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it